Yan Ning
Impact in
-
- Cancer-related molecular mechanisms research
- Protease and Inhibitor Mechanisms
-
- Peptidase Inhibition and Analysis
- Cancer Cells and Metastasis
Papers in
-
- RNA modifications and cancer 5
- Wnt/β-catenin signaling in development and cancer 2
-
- Cancer-related molecular mechanisms research 4
- Cancer Genomics and Diagnostics 4
- Cancer, Lipids, and Metabolism 3
- MicroRNA in disease regulation 2
- Co-authors
- M. Sharon Stack (1 shared paper)Laurie G. Hudson (1 shared paper)Brian P. Adley (1 shared paper)Karen D. Cowden Dahl (1 shared paper)Jaime Symowicz (1 shared paper)David A. Fishman (1 shared paper)Heinz‐Josef Lenz (11 shared papers)Dongyun Yang (9 shared papers)
- Journals
- Journal of Clinical Oncology (7 papers)Aging (1 paper)Molecular Cancer Therapeutics (1 paper)Cancers (1 paper)Clinical Colorectal Cancer (1 paper)
- Partner nations
- United StatesChinaJapan
In The Last Decade
Yan Ning
19 papers receiving 406 citations
Peers
Comparison fields: 5 of 76
- Cancer Research 113
- Oncology 153
- Developmental Biology 10
- Gastroenterology 25
- Pulmonary and Respiratory Medicine 134
Countries citing papers authored by Yan Ning
This map shows the geographic impact of Yan Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yan Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yan Ning more than expected).
Fields of papers citing papers by Yan Ning
This network shows the impact of papers produced by Yan Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yan Ning. The network helps show where Yan Ning may publish in the future.
Co-authors
The 25 scholars most cited alongside Yan Ning, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 165 | |
| 2 | 2008 | 152 | |
| 3 | 2018 | 17 | |
| 4 | 2014 | 14 | |
| 5 | 2022 | 12 | |
| 6 | 2021 | 10 | |
| 7 | IMP3 is upregulated in primary ovarian mucinous carcinoma and promotes tumor progression. | 2017 | 9 |
| 8 | 2018 | 8 | |
| 9 | 2018 | 6 | |
| 10 | 2018 | 6 | |
| 11 | 2021 | 4 | |
| 12 | 2020 | 4 | |
| 13 | 2020 | 4 | |
| 14 | 2015 | 1 | |
| 15 | 2016 | 1 | |
| 16 | 2012 | 1 | |
| 17 | 2013 | 1 | |
| 18 | 2015 | 1 | |
| 19 | 2016 | 1 | |
| 20 | 2017 | 0 |
About Yan Ning
Yan Ning is a scholar working on Molecular Biology, Cancer Research, Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 20 papers that have together received 417 indexed citations. Recurring topics across this work include RNA modifications and cancer (5 papers), Colorectal Cancer Treatments and Studies (4 papers), Cancer-related molecular mechanisms research (4 papers), Cancer Genomics and Diagnostics (4 papers), Cancer, Lipids, and Metabolism (3 papers), MicroRNA in disease regulation (2 papers), Genetic factors in colorectal cancer (2 papers) and Wnt/β-catenin signaling in development and cancer (2 papers). The work is most often cited by research in Cancer Research (113 citations), Oncology (153 citations), Developmental Biology (10 citations), Gastroenterology (25 citations) and Pulmonary and Respiratory Medicine (134 citations). Yan Ning has collaborated with scholars based in United States, China and Japan. Frequent co-authors include M. Sharon Stack, Laurie G. Hudson, Brian P. Adley, Karen D. Cowden Dahl, Jaime Symowicz, David A. Fishman, Heinz‐Josef Lenz, Dongyun Yang, Thomas Winder and Georg Lurje. Their work appears in journals such as Journal of Clinical Oncology, Aging, Molecular Cancer Therapeutics, Cancers and Clinical Colorectal Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.